IDPC and project partners have presented a series of policy guides to advocate reforms in drug and sentencing policies in South East Asia aiming to reduce incarceration and protect the rights of the incarcerated.
Next March, we hope that governments will acknowledge the disastrous human rights impacts of the last decade (and beyond) and openly admit that there is no progress to speak of towards eliminating the global drug market.
The INCB Watch is running a short series of posts to explore how the Board has changed – or remained the same – over the past decade or so. This post gives an overview of the areas we will analyse in the course of this project.
The divergence between the Commission’s progressing stance on legal regulation and Trump’s Global Call to Action reminds us of the many obstacles facing drug policy reform. But it is also a promising reminder of the waning hegemony of the war on drugs rhetoric.
Far from an effort at achieving mutual understanding and genuine consensus on drug policy, the "Global Call to Action" is yet another instance of heavy-handed U.S. “with us or against us” diplomacy.
A side event at the Commission on Narcotic Drugs brought together experts to discuss how drug policy outcomes are measured, with the Sustainable Development Goals discussed as a potential mechanism of evaluation.
There is still a long way to go. But what is clear though is that the combined efforts from academia, policy circles, and the involvement of the grassroots in the development of solutions can pave the way for more systematic responses to the tough questions on illicit economies.
